- Home
- WAFU vs PULM Comparison
WAFU vs PULM Comparison
Compare WAFU & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WAFU | PULM |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 6.2M |
| IPO Year | 2017 | 2013 |
Fundamental Metrics
Financial Performance| Metric | WAFU | PULM |
|---|---|---|
| Price | $1.49 | $1.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 317.1K | 41.9K |
| Earning Date | 07-31-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,910,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5069.93 |
| 52 Week Low | $1.22 | $1.16 |
| 52 Week High | $3.06 | $5.50 |
Technical Indicators
Market Signals| Indicator | WAFU | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 55.00 | 58.66 |
| Support Level | $1.30 | $1.61 |
| Resistance Level | $1.72 | $1.66 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 27.42 | 67.27 |
Price Performance
Historical ComparisonAbout WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).